Listen to learn the fundamentals on specialized agents for treatment-experienced people living with HIV and to learn how you can leverage these agents’ unique attributes to devise effective antiretroviral treatment strategies.

Listen as Dr Josep M. Llibre reviews the essentials on ART selection for treatment-experienced people with HIV and comorbidities, including key principles for designing ART regimens for persons with multidrug-resistant HIV and considerations for comorbidities and drug–drug interactions.

Tune in for a quick and easy primer on how to recognize key populations who may present with multidrug-resistant HIV, identify underlying reasons for regimen failure, and evaluate resistance profiles to construct new ART regimens.

In this podcast, listen as Dr Palak Trivedi catches you up on the most recent developments in primary biliary cholangitis (PBC) treatment, discussing cutting-edge data on new and emerging agents and providing insight into how these updates may be integrated into your practice. 

Listen as expert faculty, Robert H. Hopkins, Jr., MD, MACP, and Litjen (L.J.) Tan, MS, PhD, answer your most pressing questions on optimizing immunization in clinical practice, including strategies to tailor recommendations, navigating clinical encounters, and achieving vaccine expertise.

In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss actionable strategies for healthcare professionals to put into practice regarding the care of patients with primary biliary cholangitis (PBC).

In this podcast, Sonal Kumar, MD, MPH, meets with patient advocate Maria Morais to discuss actionable steps that healthcare professionals can incorporate into the care of people with primary biliary cholangitis (PBC).

How should we manage primary biliary cholangitis (PBC) in people with high ALP levels? Listen to learn more about the role of ALP and the biochemical response in PBC management from expert faculty, Dr Stuart Gordon and Dr Nancy Reau, as they discuss an illustrative patient case and explain what to expect from treatment.

Listen as expert faculty, Dr Stuart Gordon and Dr Nancy Reau, discuss an illustrative patient case to demonstrate how they individualize primary biliary cholangitis (PBC) therapy for patients with cirrhosis.

Listen in as a respiratory diseases expert and radiology expert discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE.

In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss how they assess the symptoms of primary biliary cholangitis (PBC) and explore how new therapeutic agents may help alleviate symptom burden.

How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including how and when to measure treatment response; evidence-based goals of therapy; and considerations for second-line treatment.

In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV.

Listen in as Carolyn Bridges, MD, FACP, and Laura P. Hurley, MD, MPH, discuss barriers to RSV vaccination for adults, including insurance coverage and vaccine hesitancy, and explore effective, practical strategies for overcoming these barriers.

Listen in as Carolyn Bridges, MD, FACP, reviews the estimated burden of RSV disease in older adults and discusses the latest updates on RSV vaccination recommendations and safety data.

Listen to Jewel Mullen, MD, MPH, MPA, and Dallas Nelson, MD, CMD, FACP, to learn effective strategies for overcoming barriers to RSV vaccine uptake in post-acute and long-term care facilities, including incorporating the latest RSV vaccination recommendations, navigating insurance, and addressing vaccine hesitancy.

Chloe Orkin, MBChB, FRCP, MD, and Jean-Michel Molina, MD, PhD, review key findings from clinical trials on HIV prevention and treatment as well as sexually transmitted infection prevention presented at CROI 2025.

Listen in as expert faculty discuss treatment strategies for people with severe COVID-19 who are immunocompromised, including how to effectively use antiviral therapy, dexamethasone, and other immunomodulators in this population.

Listen in as expert faculty discuss treatment options for people with severe or critical COVID-19 and review data supporting the use of antiviral therapy, steroids, and other immunomodulators.

In this episode, tune in to listen as Dr Patricia Jones, Dr Mindie Nguyen, and patient advocate Jennifer Wild discuss practical strategies to overcome barriers to hepatitis B virus (HBV) care, including improving access to HBV care in immigrant communities, dispelling HBV myths and stigma, and community-based interventions.